Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
流行病缓解措施对呼吸道病原体和抗生素抗性基因定植和传播的影响
基本信息
- 批准号:10510137
- 负责人:
- 金额:$ 25.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-08 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAdenovirusesAdultAntibiotic ResistanceAntibiotic TherapyBacteriaCOVID-19 pandemicCalendarChildClinicalDetectionDevelopmentDiseaseDwarfismEffectivenessExhibitsFaceGene ExchangesHomeHouseholdHumanInfectionInfluenzaInterruptionMeasurementMeasuresMobile Genetic ElementsModelingMonitorNasopharynxNatureOrganismPathogenesisPathogenicityPatternPeruPneumococcal ColonizationPneumoniaPrevention strategyProcessRecommendationRespiratory Signs and SymptomsRespiratory Tract InfectionsRespiratory syncytial virusRhinovirusRiskSARS-CoV-2 transmissionSamplingSchoolsStaphylococcus aureusStreptococcus pneumoniaeSymptomsTestingTimeVaccinationVaccinesViral Respiratory Tract InfectionVirus DiseasesVisitbaseclinically relevantcommunity transmissionhuman coronavirusmemberpandemic diseasepathogenprospectiveresistance generespiratoryrespiratory colonizationrespiratory pathogenrespiratory virussuccesssurveillance datatransmission processvaccine development
项目摘要
ABSTRACT
Nasopharyngeal (NP) colonization with commensal and pathogenic organisms is common and a
dynamic process. While these dynamics typically occur in the healthy state, many respiratory viruses and
colonizing bacteria are important causes of acute respiratory illness (ARI) and invasive disease. Respiratory
viruses and bacteria also exhibit interactions that are important in ARI pathogenesis. The initial period shortly
after acquisition of respiratory bacteria or infection with respiratory viruses is particularly critical, imparting an
increase in ARI risk. S. pneumoniae, S. aureus, and other colonizing bacteria also commonly express antibiotic
resistance genes that may be transferred or exchanged between co-colonizing organisms.
Broad mitigation strategies were implemented for SARS-CoV-2 pandemic control in many settings,
including use of face coverings, stay-at-home orders, and school closures. Collectively, these efforts were
associated with reduced community transmission of SARS-CoV-2. In addition, ecologic studies during these
periods also demonstrated interruptions in influenza, respiratory syncytial virus, and S. pneumoniae disease
activity that were very substantial, dwarfing the success of existing preventive strategies, including vaccines,
which are available against only few respiratory pathogens and limited in their scope and effectiveness.
Understanding the impact of mitigation strategies on the activity of colonizing respiratory pathogens beyond
SARS-CoV-2 would inform efforts to understand infection dynamics and reduce the burden of these common
yet currently unpreventable infections.
We conducted intensive household-based ARI surveillance in Lima, Peru during the same period in two
consecutive years: 2019, just prior to the COVID-19 pandemic, and 2020, during peak SARS-CoV-2 activity.
We aim to leverage this unique platform to characterize patterns of household acquisition and infection with
respiratory pathogens during periods with and without mitigation strategies through the conduct of two Specific
Aims: 1) To test the hypothesis that mitigation strategies are associated with a) fewer acquisitions of colonizing
respiratory bacteria, b) fewer infections with respiratory viruses, shorter durations of colonization/detections,
and reduced transmission of these pathogens among children and adults in households in semi-urban Peru,
and 2) To test the hypothesis that mitigation strategies are associated with fewer acquisitions, shorter duration
of detection, and reduced household transmission of nasopharyngeal antibiotic resistance genes among
children and adults in households in semi-urban Peru. A detailed understanding of the impact of these
mitigation strategies on the dynamics of colonization with clinically relevant respiratory pathogens may inform
targeted applications to reduce the global impact of ARI and pneumonia, particularly for infections that are not
yet vaccine-preventable.
抽象的
共生生物和病原生物在鼻咽 (NP) 定植很常见,并且
动态过程。虽然这些动态通常发生在健康状态下,但许多呼吸道病毒和
定植细菌是急性呼吸道疾病 (ARI) 和侵袭性疾病的重要原因。呼吸系统
病毒和细菌也表现出在 ARI 发病机制中很重要的相互作用。初期不久
在获得呼吸道细菌或感染呼吸道病毒后尤为重要,
ARI 风险增加。肺炎链球菌、金黄色葡萄球菌和其他定植细菌也通常表达抗生素
抗性基因可以在共定殖生物体之间转移或交换。
在许多情况下,为控制 SARS-CoV-2 大流行实施了广泛的缓解策略,
包括使用面罩、居家令和学校停课。总的来说,这些努力是
与 SARS-CoV-2 社区传播减少有关。此外,这些时期的生态学研究
期间还表现出流感、呼吸道合胞病毒和肺炎链球菌疾病的中断
活动规模非常大,使包括疫苗在内的现有预防战略的成功相形见绌,
这些药物只能针对少数呼吸道病原体,并且其范围和有效性有限。
了解缓解策略对呼吸道病原体定植活动的影响
SARS-CoV-2 将为了解感染动态并减轻这些常见疾病的负担提供信息
但目前无法预防的感染。
我们在两个时期的同一时期在秘鲁利马进行了密集的家庭 ARI 监测
连续几年:2019 年,即 COVID-19 大流行之前,以及 2020 年,在 SARS-CoV-2 活动高峰期。
我们的目标是利用这个独特的平台来描述家庭感染和感染的模式
在有或没有缓解策略期间,通过进行两种特定的措施来控制呼吸道病原体
目标: 1) 检验缓解策略与以下因素相关的假设:a) 减少殖民获取
呼吸道细菌,b) 呼吸道病毒感染较少,定植/检测持续时间较短,
并减少了这些病原体在秘鲁半城市家庭中儿童和成人之间的传播,
2) 检验缓解策略与更少的收购、更短的持续时间相关的假设
检测,并减少鼻咽部抗生素抗性基因的家庭传播
秘鲁半城市家庭中的儿童和成人。详细了解这些影响
临床相关呼吸道病原体定植动态的缓解策略可能会提供信息
有针对性的应用程序,以减少急性呼吸道感染和肺炎的全球影响,特别是非传染性疾病
但可以通过疫苗预防。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLOS G GRIJALVA其他文献
CARLOS G GRIJALVA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLOS G GRIJALVA', 18)}}的其他基金
Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program
秘鲁范德比尔特 — 通过疫苗接种培训进行预防 (PREVENT) 计划
- 批准号:
10674393 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease
人类鼻病毒感染以及对 SARS-CoV-2 感染和症状性疾病的易感性
- 批准号:
10726391 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
流行病缓解措施对呼吸道病原体和抗生素抗性基因定植和传播的影响
- 批准号:
10641008 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
Gestational diabetes drugs and perinatal outcomes in underserved populations
妊娠糖尿病药物和服务不足人群的围产期结局
- 批准号:
10487395 - 财政年份:2021
- 资助金额:
$ 25.95万 - 项目类别:
Gestational diabetes drugs and perinatal outcomes in underserved populations
妊娠糖尿病药物和服务不足人群的围产期结局
- 批准号:
10193041 - 财政年份:2021
- 资助金额:
$ 25.95万 - 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
- 批准号:
10555283 - 财政年份:2020
- 资助金额:
$ 25.95万 - 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
- 批准号:
10094190 - 财政年份:2020
- 资助金额:
$ 25.95万 - 项目类别:
Mentoring in transmission of influenza and strategies for prevention
流感传播的指导和预防策略
- 批准号:
10356800 - 财政年份:2020
- 资助金额:
$ 25.95万 - 项目类别:
Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science
学习健康系统培训计划:PROgRESS--患者/实践成果以及有效性和系统科学的研究
- 批准号:
10192698 - 财政年份:2018
- 资助金额:
$ 25.95万 - 项目类别:
Learning Health System training program: PROgRESS-- Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science
学习健康系统培训计划:进展——患者/实践成果以及有效性和系统科学的研究
- 批准号:
10747558 - 财政年份:2018
- 资助金额:
$ 25.95万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
- 批准号:
10639707 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Natural model for evaluating within- and cross-species virus transmission
评估物种内和跨物种病毒传播的自然模型
- 批准号:
10735974 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Optimizing the Generation of Monoclonal Antibodies for Prevention and Treatment of HSV Disease
优化用于预防和治疗 HSV 疾病的单克隆抗体的生成
- 批准号:
10717320 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Adjuvant effect of physical exercise on immune response to COVID-19 vaccination and interactions with stress
体育锻炼对 COVID-19 疫苗接种免疫反应的辅助作用以及与压力的相互作用
- 批准号:
10593597 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别: